PERIPHERAL ARTERIAL DISEASE (PAD) is a disorder affecting 15% of adults over 55; it results in insufficient blood flow during exercise (intermittent claudication) or rest. Patients with PAD have a 25% higher mortality rate and risk amputation (50,000 cases/year in the United States; Refs. 6, 62) . Currently, rehabilitative exercise training is regarded as the most effective treatment for intermittent claudication, but it is only applied to select patients and its therapeutic mechanisms are poorly understood (46) .
New therapies for PAD and preclinical models of PAD are generating intense interest (62) . The most common animal model of PAD is surgical ligation of one or both of the femoral or iliac arteries (single or double ligation). Although neither method completely reproduces the symptoms of PAD (and they are a more acute pathology than the chronic course of human PAD), they are valuable tools for studying PAD in several animal species including rat, mouse, and rabbit (3, 28, 41, 43, 47, 53) . After ligation, the affected leg loses blood flow (becomes unperfused) due to functional loss of a major artery, but blood reperfusion begins within the first 2 wk due to collateralization (growth and dilation of smaller arteries and vessels; Refs. 4, 16) . Blood flow and tissue oxygen content partially recover to acceptable levels at rest, but limb activity is hindered and blood perfusion during exercise cannot reach preligation levels (3, 14, 41) . It is this animal model of PAD (femoral ligation) for which we created a computational model in this study.
VEGF is a key promoter of both physiological and pathological angiogenesis. It increases proliferation and migration of endothelial cells and is widely studied in vivo and in vitro (8, 18, 54, 55, 60) . VEGF acts as a chemoattractant and directs capillary growth, so angiogenic response to VEGF depends on both VEGF concentration and extracellular gradients of VEGF (12, 15) . In PAD, delivery of VEGF via bolus injection, adeno-associated viral vector, or transplantation of proangiogenic cells has shown great therapeutic potential by increasing blood perfusion and tissue oxygenation, but each mode of delivery requires further investigations to confirm its effectiveness and safety (9, 19, 56 ). An alternative proangiogenic therapy is exercise training, which has promising results and a low potential for harmful side effects (3, 24, 62) . However, more investigation is needed to better understand VEGFinduced angiogenesis and its application to PAD.
A variety of cells in the body, including myocytes (skeletal muscle fibers), secrete VEGF at different rates (65) . Five main splice variant proteins are produced from the VEGF-A gene, and isoforms 120 and 164 (corresponding to the number of amino acids) are the most frequently expressed (25, 40, 48) . VEGF 120 and VEGF 164 are both homodimeric glycoproteins, but only VEGF 164 contains a domain that allows it to bind to neuropilin-1 (NRP1) coreceptors expressed on endothelial cell surfaces and to heparan sulfate proteoglycans (HSPG) present in high concentrations in the extracellular matrix and basement membranes of the interstitial space. VEGF signaling occurs by VEGF binding to receptor tyrosine kinases VEGFR1 and VEGFR2, causing the two VEGF receptors (VEGFRs) to signal intracellularly (55) ; the receptor-ligand complex may also be internalized, thus removing VEGF from the interstitial space. The coreceptor NRP1 modulates VEGF binding to receptors due to its ability to form VEGF 164 -VEGFR2-NRP1 and VEGF 120 -VEGFR1-NRP1 complexes ( Fig. 1; Ref. 55 ).
Hindlimb arterial ligation causes large areas of tissue to become unperfused, leading to hypoxia (47) . In normal muscle, hypoxia is detected by the oxygen sensing transcription factor hypoxia inducible factor (HIF) 1␣, which stimulates VEGF upregulation (58) . In ligated rats, the response to hypoxia changes and expression of VEGF, VEGFRs, and VEGF coreceptor NRP1 is different for exercise-trained vs. nontrained rats (28) . To gain a better understanding of angiogenesis in PAD and the therapeutic angiogenic effect of exercise training, we must study the interaction of VEGF with both blood perfused and unperfused muscle in both exercise-trained and nonexercise-trained animals during rest and exercise throughout the course of PAD.
The interactions of VEGF ligands with their receptors and coreceptors are very complex, especially when spatial gradients are present, and it is impossible to achieve a quantitative understanding of this system using experimental methods alone. Computational/systems biology is emerging as a powerful methodology for studying complex systems from the molecular to tissue and organ levels. We have previously constructed models studying VEGF interactions with receptors in normal rat extensor digitorum longus (EDL) and in human vastus lateralis muscle (29 -31, 33) and interactions with NRP1 and placental growth factor in vitro (32, 34) . In this study, we constructed a computational model to investigate the biochemical interactions and transport of VEGF in vivo using the well-characterized hindlimb muscle in rat as a sample environment. We used an empirical relationship between VEGF secretion and oxygen concentration consistent with experimental data on HIF1␣ response to oxygen combined with data on VEGF secretion in response to changes in HIF1␣ (22, 58) . This is the first computational model of VEGF transport in vivo under conditions of PAD in exercise-trained and nonexercisetrained rats that can predict VEGF distribution at spatial resolutions currently impossible to achieve experimentally. Use of this model will aid in understanding of the effect of NRP1 on VEGF gradients and of the effect of exercise training therapy on PAD. The model allows the analysis of exerciseinduced VEGF and VEGF receptor upregulation over a 14-day period leading up to vascular remodeling, including hypoxiainduced VEGF upregulation, formation of VEGF gradients, and angiogenic activation of endothelial cells by VEGF signaling. Data from femoral ligation experiments will be used for the upregulation of VEGF and its receptors during simulated PAD and exercise. This model is also general enough to be applicable to other tissue types in the future.
METHODS
We have constructed a 400 ϫ 208 ϫ 800 m 3 three-dimensional model of rat EDL muscle (including muscle fibers, microvessels, extracellular matrix, and basement membranes) based on experimental observations ( Fig. 1 ; Refs. 3, 5, 11, 18, 23, 36 -38, 58, 59 ). This three-dimensional model is used in calculations of blood flow and oxygen distributions from which VEGF secretion from the myocytes , and neuropilin-1 (NRP1) (denoted 1, 2, and N, respectively). VEGF164-VEGFR2-NRP1 complexes can be formed when VEGF164-bound NRP1 couples with unbound VEGFR2 or when VEGF164-bound VEGFR2 couples with unbound NRP1. VEGF120-VEGFR1-NRP1 and VEGFR1-NRP1 complexes can be formed when NRP1 couples with VEGF120-bound or unbound VEGFR1. All VEGF-bound and unbound receptors can be internalized.
is estimated as described below. However, due to the complexity of the system and the number of the parameters that are of physiological interest that need to be explored, we chose a two-dimensional tissue cross section (400 ϫ 208 m 2 ) in which we will characterize the VEGF gradients (Fig. 2) . Using empirical relationships for viscosity and hematocrit distribution (21, 42) and blood oxygenation and velocity measurements in ligated rat EDL as parameters (13, 14, 41, 42) , we simulated blood flow for both fully perfused tissue (FPT) and partially perfused tissue (PPT) where only half of the tissue arterioles have blood flow (Fig. 2) . In vivo, there are heterogeneous blood flow distribution in tissues, and some parts of a tissue are reperfused before others. Thus, in both the FPT and PPT, perfusion returns over the course of 14 days. They are both models of femoral ligation and subsequent perfusion recovery for different parts of the muscle experiencing different blood flows.
As in a previous study (21), we used blood flow simulation results to perform oxygen transport simulations for resting and exercising conditions ( Fig. 2 ; Refs. 2, 18, 21) . Using experimental data on the dependence of VEGF release on HIF1␣ and O 2 (22, 28, 45, 58) , we formulated an empirical relationship between oxygen tension and VEGF release at the level of a single myocyte (Fig. 3) . Finally, using parameters for expression and transport of VEGF (10, 27, 34, 35, 40, 51, 52, 58, 65) , expression and binding kinetics of VEGFRs and NRP1 (10, 28, 32, 34, 52, 63) , and the simulated oxygen distributions, we performed VEGF transport simulations in a two-dimensional slice of EDL tissue for rat with surgically ligated artery upstream (as a model of PAD).
The time-course changes in blood oxygen content in ligation/PAD are based on experimental measurements for blood oxygenation and tissue oxygenation. In nondiseased tissue, blood oxygen saturation of arterioles feeding into capillaries (SO 2A) is 0.6 -0.8 (20, 61) . Although SO2A has never been directly measured in skeletal muscle with PAD, tissue PO2 measurements and values of hemoglobin saturation estimated from the PO2 data show an immediate decrease in overall hemoglobin saturation after arterial ligation with a steady recovery over 14 days (13, 14, 41) . Therefore, SO 2A values of 0.06, 0.3, and 0.6 are used for 2, 7, and 14 days after ligation, respectively. These lower upstream oxygen contents are used to model the slow return of oxygenating flow to the tissue.
While nonexercise-trained rats are assumed to have no VEGFR or NRP1 upregulation based on experimental measurements, for exercise-trained rats we performed VEGF transport simulations using the derived O 2-VEGF relationship and experimentally measured VEGFR and NRP1 expression upregulation levels for 2, 7, and 14 days after ligation for resting and exercising muscle.
The time period in this study ends at 14 days. We assume that vascular remodeling is limited within this time; after this, varying amounts of vascular remodeling would take place in exercise-treated and untreated muscles. These VEGF-dependent changes to the vascular networks would necessitate a feedback loop in which the blood flow and tissue oxygen levels are recalculated, having a follow-on effect on VEGF release and VEGFR binding. Such an iterative process can be implemented, but comprehensive, consistent quantitative data are not presently available on how the endothelial cells respond to the VEGFR binding and VEGF gradients, and thus this is beyond the scope of this study.
An expanded METHODS section containing the description of the model geometry, complete governing equations, model parameters, and details of the numerical solution is available in the online data Supplemental Materials at http://ajpheart.physiology.org/. The development of the kinetic network of interactions between the VEGF ligands and the VEGF receptors on the cell surface (33) and the development of the EDL model (29 -31) have taken place incrementally over several publications.
RESULTS
Three-dimensional simulations of oxygen distribution in hindlimb ischemia. In PAD, ischemic tissue maintains normal oxygen consumption, but blood flow in microvessels becomes more heterogeneous and only some arterioles remain perfused. During and after the collateralization process, the unperfused tissue becomes hypoxic and angiogenesis takes place, resulting in the increase of capillary-to-fiber ratios in the tissue (13, 38, 41) . We performed simulations to study the effect of blood flow loss in regions of unperfused tissue and the effect of light exercise on oxygen distribution in FPT and PPT.
In FPT with normal blood oxygenation [i.e., inlet arteriole SO 2 (SO 2A ) is 0.6], the entire tissue remains well oxygenated (PO 2 Ͼ 22 mmHg; Fig. 2A ). During light exercise, tissue oxygen consumption is assumed to be sixfold resting level and capillary blood flow velocity increases 180% (3) . No regions of extreme hypoxia (PO 2 Ͻ 1 mmHg) exist, but the minimum PO 2 level decreases to 3 mmHg (Fig. 2C) .
In PPT, at rest, oxygen diffuses a minimum of 80 m from the perfused region into the unperfused region, so only 34% of the unperfused region is hypoxic (Fig. 2B) . During light exercise, the perfused region can no longer oxygenate the unperfused region, so the entire unperfused region becomes hypoxic (Fig. 2D) . These results and other oxygen simulations are used in the following sections to predict VEGF secretion rate from individual muscle fibers.
Two-dimensional simulations of VEGF distribution for different levels of NRP1. Absolute concentration of NRP1 has not been measured in EDL or any other muscle, but in explanted human endometrium, NRP1 mRNA is one-to twofold VEGFR2 levels. Extrapolating this ratio we would expect ϳ10 4 NRP1/cell in accordance with our calculated concentrations of VEGFR2 in skeletal muscle (29, 44) . Hence, we simulate uniform secretion of VEGF from muscle fibers and express 0, 10 3 , 10 4 , or 10 5 NRP1/cell. Altering NRP1 expression changes interstitial unbound VEGF concentration, so we alter VEGF secretion rates accordingly to obtain the experimentally observed unbound VEGF concentration of 1 pmol/l (17) . The results are presented in Table 1 and Supplemental Fig. S1 .
VEGF gradients are measured relative to the average unbound VEGF concentration in the interstitial space (relative gradients). They are calculated as the local change in VEGF concentration across 1 m of interstitial space and are reported as change in VEGF concentration across 10 m, divided by mean VEGF tissue concentration. Ten micrometers were chosen as a reasonable scale for chemotactic sensing. During sprout formation, a tip cell with a length of 30 -50 m is leading the sprout (12, 50) and thus the tip cell could experience gradients several times larger than the values reported per 10 m.
Average VEGF gradients increase from 2.9 Ϯ 3.6 to 10.2 Ϯ 11.4%VEGF/10 m (ϮSD) when 10 5 NRP1/cell is expressed (vs. no NRP1 expression). Gradients are mainly due to the heterogeneous placement of the capillaries. VEGF concentration is lowest in regions of high capillarity because receptors on capillary cell surfaces are internalized, and VEGF is removed from the interstitial space (Supplemental Fig. S1 ). Two-dimensional simulations of VEGF distribution for arterial ligation: nonexercise-trained rat. For nonexercise-trained rats with ligated arteries, no consistent trend in receptor expression can be observed from measurements, and different observations are reported on whether VEGFR1 is up-or downregulated in ischemia (28, 38) . However, the evidence agrees that the change in VEGFR1 and VEGFR2 expression in rat is Ͻ70%, so we perform simulations of VEGF distribution assuming no changes in VEGFR expression for fully and partially perfused muscle.
Experimental measurements suggest that unlike healthy tissue, where decreasing environmental oxygen alone is sufficient to double VEGF mRNA expression (58), muscle with PAD (or ligated artery) upregulates VEGF (mRNA and protein) Ͻ50% even in the hypoxic environment shortly after ligation (28, 38, 43) . We assume that uniform secretion (with 10 4 NRP1/cell) is representative of EDL in ligated hindlimb (Supplemental Fig.  S1C ). VEGF gradients average 3.3 Ϯ 3.9%VEGF/10 m, and maximum VEGFR2 binding is 278 molecules/cell.
Two-dimensional simulations of VEGF distribution for arterial ligation: exercise-trained rats during exercise. In exercise-trained rats with PAD, mRNA expression of VEGF, VEGFRs, and NRP1 can be upregulated several fold (Fig. 4 , muscle during exercise periods; Fig. 5 , muscle during rest periods). For these muscles, we simulate and compare VEGF transport in FPT and PPT using our oxygen-dependent model of VEGF secretion (Fig. 3) and measurements for VEGFR and NRP1 expression for exercise-trained rats with femoral ligation (28) . Control conditions assume normal blood oxygenation (SO 2A ϭ 0.6) and basal tissue receptor expression for both PPT (Figs. 4 and 6A) and FPT ( Fig. 6A; Supplemental Fig. S2 ). VEGF gradients are similar (3.6 Ϯ 4.1 vs. 3.7 Ϯ 4.1%VEGF/10 m average, FPT vs. PPT), but maximum VEGFR2 binding is higher in the unperfused region of PPT (1,420 vs. 961 molecules/cell). Two days after ligation, blood flow oxygenation is severely impaired (SO 2A ϭ 0.06), and our simulations predict that the tissue becomes completely hypoxic. Using Eq. 1 (Supplemental Materials), we predict that fibers will uniformly secrete VEGF at sixfold resting for both FPT and PPT, so no difference in VEGF transport is expected. VEGFRs are upregulated (Fig. 4) , which allows VEGFR2 to bind more VEGF (1,810 molecules/cell maximum) and increases VEGF gradients (11.3 Ϯ 12.4%VEGF/10 m).
Seven days after ligation, VEGFR upregulation and blood oxygenation increases (SO 2A ϭ 0.3). Average VEGF gradients increase (14 Ϯ 15.8 and 14.2 Ϯ 15.9%VEGF/10 m in FPT and PPT, respectively), and maximum VEGFR2 binding remains elevated (1,620 and 1,820 molecules/cell in FPT and PPT, respectively). Two weeks after ligation, significant angiogenesis may have occurred, but we assume that the initial vessel network remains unchanged to compare VEGF gradients and VEGFR binding to the first week after ligation. Blood oxygenation is restored (SO 2A ϭ 0.6), so FPT is no longer hypoxic and VEGFR upregulation is reduced. In FPT and PPT, average VEGF gradients decrease to 5.2 Ϯ 5.9%VEGF/10 m and maximum VEGFR2 binding is reduced (but higher in PPT: 1,260 and 1,680 molecules/cell for FPT and PPT, respectively). In the first 2 wk after ligation, the balance among VEGF, VEGFR, and NRP1 upregulation maintains average interstitial unbound VEGF concentrations between 0.9 and 1.7 pmol/l (compared to 1 pmol/l for nondiseased resting muscle).
Two-dimensional simulations of VEGF distribution for arterial ligation: exercise-trained rats during rest. Exercisetrained rats spend 22 h/day at rest (28) . We simulated VEGF distributions using oxygen distributions for resting EDL to determine VEGF secretion and the same parameters for VEGFR and NRP1 expression as exercise-trained rat during exercise. Here, the differences between FPT and PPT are more pronounced (Figs. 5 and 6B) .
Two days after ligation, both FPT and PPT are completely hypoxic; therefore, no difference is expected between simulations during exercise and rest (Fig. 4B) . Seven days after ligation, VEGF gradients in both FPT (Fig. 5A) and PPT (Fig.  5C ) are high (12.3 Ϯ 13.6 and 12.6 Ϯ 14.5% VEGF/10 m, respectively). However, maximum VEGFR2 binding is much higher in PPT (1,810 vs. 332 molecules/cell). Two weeks after ligation, assuming no angiogenesis occurred, blood oxygenation is restored and VEGF gradients decrease in both FPT and PPT (5.0 Ϯ 5.9 and 5.3 Ϯ 6.4% VEGF/10 m, respectively). However, maximum VEGF-bound VEGFR2 remains higher in PPT (1,670 vs. 322 molecules/cell).
DISCUSSION
Recovery from PAD requires formation of new, functional blood vessels by collateralization and angiogenic sprouting. Initiation of angiogenic sprouting and guidance of the sprouts are dependent both on the overall concentration of VEGF and on the VEGF gradients. The ability to modulate VEGF gradients and understand angiogenesis mechanisms would greatly aid research into therapies for PAD, but these gradients cannot http://ajpheart.physiology.org/ be measured experimentally with present technology. The goal of this study was to quantitatively predict VEGF concentrations, gradients, and receptor signaling in vivo. We have constructed an anatomically detailed and biophysically accurate computational model of VEGF transport and interaction with its receptors based on the fundamental equations of mass balance and biochemical kinetics and performed computer simulations using parameters obtained from the experimental literature. Our model integrates the molecular biology of VEGF with in vivo tissue physiology (including blood flow and oxygen transport) to predict how PAD, or its animal model equivalent, femoral artery ligation, changes VEGF distributions and the beneficial potential of exercise training during PAD.
We have developed two types of models for studying VEGF receptors in skeletal muscle in vivo. The model of VEGF gradient formation in rat EDL was previously explored without the inclusion of NRP (29, 31) . VEGF interactions with VEGF receptors and with NRP in human vastus lateralis muscle have been studied without the inclusion of VEGF gradients (33) . Here we include the NRP interactions in the rat EDL model and study the effects of exercise training on VEGF gradients and VEGF receptor binding.
Experiments have not shown whether endothelial tip cells respond to HSPG-bound VEGF. We present VEGF gradients as changes in unbound VEGF concentration relative to average interstitial VEGF concentration. The relative gradients (%VEGF/10 m) of unbound and total (unbound plus HSPG bound) VEGF are the same because the low fractional occupancy of HSPG (Ͻ1%) results in a linear relationship between unbound and HSPG-bound VEGF concentration. Absolute gradients of HSPG-bound VEGF are larger, as the average HSPG-VEGF concentration is predicted to be 50 -100 times the free VEGF concentration (33) (due to the unavailability of data for the number and affinity of binding sites for VEGF in extracellular matrix in vivo, these predictions are based on parameters extrapolated from other growth factors, e.g., fibroblast growth factor; Ref. 10 ). This assumes that HSPG concentration is uniform throughout the nonbasement membrane interstitial space, which may not be true. Furthermore, during angiogenesis, proteases can focally cleave and release HSPGbound VEGF (26) . However, in this study, we present steadystate VEGF distributions for a sample homogeneous interstitial space.
NRP1 can have a significant effect on both VEGF gradients and VEGFR binding kinetics; hence, NRP1 is an important molecule for VEGF signaling and guidance in both healthy and diseased states. Our simulations show that expression of 10 4 NRP1/cell increases VEGFR2 binding by 170% and decreases VEGFR1 binding by 75%; expression of 10 5 NRP1/cell increases average VEGF gradients by Ͼ200% (vs. no NRP1 expression). Therefore, upregulation of NRP1 in addition to upregulation of VEGF may be more effective than upregulation of VEGF alone. Furthermore, the relationship between VEGFR binding and NRP1 expression is complex and dependent on relative concentrations of NRP1, VEGFR1, and VEGFR2. Hence, the basal concentration of NRP1 and changes in expression of NRP1 in healthy and diseased muscle are critical for understanding angiogenesis and the potential for NRP1 to be a target for proangiogenic therapy.
We do not include soluble VEGFR1 (sFlt1) in this study. There are currently no data on the relative amounts of soluble vs. membrane-bound VEGFR1 and whether this ratio changes under conditions of PAD or during exercise. While the presence of soluble VEGFR1 acting as a sequestering agent for VEGF will affect the transient changes in the binding of VEGF to membrane-bound VEGF receptors, at steady state there would be no change due to sequestration, similar to the effects of changing the extracellular matrix VEGF binding site density (33) . Significant heterodimerization of membrane and soluble VEGF receptors would result in the formation of dummy receptors for VEGF that would affect VEGF signaling, but the propensity of soluble VEGFR1 to autodimerize (1, 49, 57) would limit this surface interaction. For the presence of such heterodimers to have an effect on the comparison between exercise-trained and untrained rats, training would have to change the soluble-to-membrane VEGFR1 ratio. An increase in this ratio would lead to a decrease in signaling of both VEGFR1 and VEGFR2, as the monomeric receptor tyrosine kinases are not activated by the soluble VEGFR1 upon dimerization.
Plasma levels of VEGF are typically found to be in the 1-pM range, similar to the interstitial free VEGF concentration. In addition, the permeability of the microvasculature of adult skeletal muscle to macromolecules of the size of VEGF is not high. Thus, convective transport of VEGF out of the tissue across the endothelium is not expected to be a significant factor and is not included in this model. In a mouse model of PAD, NRP1 expression doubles with exercise training (not measured in rat; Ref. 53). Our model predicts that the upregulation of NRP1 and VEGFRs increases average VEGF gradients over sixfold. In our model, we assume that NRP1 and VEGFR upregulation is uniform for all endothelial cells, but it is likely that expression of these receptors responds to microenvironmental cues. Nonuniform distribution of VEGFRs and NRP1 can elevate VEGF gradients to higher levels and more effectively direct angiogenic sprouts, as well as increase VEGFR binding and VEGF signaling on specific endothelial cells. The spatial distribution of NRP1 upregulation cannot be quantified with present technology to a resolution at the cellular scale required for this study, but imaging of endothelial tip cells can provide qualitative observations of heterogeneities of receptor upregulation and its effect on angiogenesis and VEGF guidance (7, 12) .
VEGF upregulation normally results from hypoxia and shear stress, and angiogenic response to hypoxia and shear stress can be synergistic (64) . However, the correlation between shear stress and VEGF release has not been quantified in vivo and its mechanism remains to be elucidated, so we used an oxygendependent model of VEGF secretion. The form of the O 2 -HIF1␣-VEGF secretion rate relationship has not been defined in vivo. We assume a nonlinear relationship, where the induction of VEGF upregulation is skewed towards conditions of severe hypoxia. This agrees with current experimental observations of oxygen-dependent VEGF release, but further study is needed to quantify the relationship between O 2 and VEGF release in vivo.
For PAD without exercise therapy, up to 16% of capillaries become unperfused in perfused regions of tissue, and the spatial distribution of these capillaries has not been measured (3) . In our analysis, we do not include stop-flow capillaries and we expect these unperfused capillaries to induce areas of local hypoxia adding to the heterogeneity of VEGF distribution.
In normal rat muscle, hypoxia is sufficient to drive VEGF upregulation in muscle (58) . However, in rats with femoral ligation/PAD, hypoxia alone cannot induce significant VEGF and VEGFR upregulation, as evidenced by the lack of VEGF upregulation in already severely hypoxic tissue and experiments with HIF1␣ in mouse (39) . The VEGF upregulation is limited to a 50% increase, and arterioles lose their ability to dilate in response to muscle contractions, which limits increased blood flow to relieve hypoxia (28, 38) . Our oxygen transport simulations show that even with twofold blood velocity achieved by exercise training, hypoxia becomes prevalent in the muscle for light exercise and it is unknown whether exercise therapy can increase blood flow to healthy levels for more intense exercise (up to 25-fold in extreme cases; Ref. 2) . We have also shown that restoration of oxygen-dependent VEGF release will greatly promote VEGF signaling and gradients, and both are crucial to proper angiogenic growth. Chronic exercise or electrical stimulation partially restores the ability of diseased muscle to increase blood flow in response to muscle contraction and upregulate expression of VEGF and its receptors (3, 37) . Understanding the limited VEGF response to hypoxia whether due to HIF1␣ or downstream signaling is important to understanding PAD and may reveal targets for gene or protein therapy or improved exercise therapy protocol that can more effectively restore normal muscle response.
Our simulations predict that the VEGF response to hypoxia can be critical for PAD therapy because it can favor angiogenic growth in unperfused tissue. In our simulations for exercisetrained rat during activity and rest, we assumed that no angiogenesis occurred by day 14 to change the capillary network in our simulations, but this may not be the case. Predicting such angiogenic growth requires a different model, beyond the scope of the present study of VEGF distribution and VEGFR signaling. However, even with no new vessels, VEGFR2 binding and VEGF gradients on days 2 and 7 are higher than the values on day 14 for FPT during activity (1,810 vs. 1,260 molecules/cell, 14 vs. 5% VEGF/10 m). This difference is expected to be more dramatic if new capillaries grow by day 14 because the improved muscle oxygenation by the new capillaries will lower VEGF secretion. Therefore, the majority of angiogenic events would be predicted to take place in the first week postligation. For PPT during exercise, although gradients are lower for day 14 (5% VEGF/10 m), VEGFR2 binding for vessels in the unperfused region can reach up to 1,680 molecules/cell, which is higher than the perfused region. VEGF gradients can reach as high as 26% VEGF/10 m in between the perfused and unperfused regions. This difference is even more apparent for tissue during rest for days 7 and 14 postligation. Maximum VEGFR2 binding is 4.5-fold higher in PPT than in FPT (Figs. 5B and 6) .
We have not included in this model the ability of the vasculature to respond to the VEGF receptor binding and VEGF gradients with angiogenesis and other vascular remodeling (the time period of study ends before remodeling). That these vascular changes are highly dependent on the VEGF family is clear, but the quantitative relationships, including for example, the dependence of vascular guidance on relative or absolute VEGF gradients, is not known. A major goal of our model is to predict the size of VEGF gradients (relative and absolute) and the level of VEGFR signaling that can be achieved in rat skeletal muscle in normal, diseased, and treated states. These predictions can be taken in parallel with experimental data of vascular changes to give a fuller picture of the outcome.
The results of our simulations also demonstrate that the scale over which the gradient holds may be important. For example, compare Fig. 5B and D. In each case, the relative gradients are similar; however, it is clear that in one case there is a consistent directional gradient across the tissue section. In the other (Fig.  5B) , the absolute gradients are lower due to lower average VEGF concentration, but also the gradients are more localized and do not persist over long distances. This may be an important distinction for the sensing of gradients, for example by filopodia, that can be up to 50 -100 m in length.
In summary, we have created a biophysically detailed model of VEGF transport in skeletal muscle of the PAD-model rat. The study shows that NRP1 is an extremely important coreceptor with a complex ability to significantly modulate VEGFR binding. We predict that in nonexercise-trained muscle with PAD, angiogenesis is hindered due to limited VEGF upregulation, signaling, and gradients. When this muscle undergoes exercise training, VEGF signaling is enhanced by upregulation of VEGFRs and NRP1 and signaling is strongest within the first week of exercise therapy. If upregulation of VEGFRs and NRP1 is not uniform on endothelial cells (i.e., expression is higher on perfused capillaries), VEGF gradients and signaling would be further enhanced. We also predict that VEGF release in response to hypoxia is important for angiogenesis to occur after the first week of exercise therapy to direct angiogenesis towards unperfused tissue. The ultimate goal of VEGF-based therapies for PAD is to initiate angiogenesis through VEGF signaling. Our study predicts that this may be achieved not only through VEGF upregulation but also upregulation of VEGFRs and NRP1.
